Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-09

Clinical Trial Update: Efficacy and Safety of Different Doses of Rituximab Therapy in Pemphigus Patients

View source ↗

Summary

A completed clinical trial evaluated the efficacy and safety of different rituximab dosing regimens in patients with pemphigus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rituximab (Rituxan) (rituximab)

Snippet

Sponsor: Ruijin Hospital | Conditions: Pemphigus Disease, Rituximab (RTx) | Status: COMPLETED